BIEFFE FIBER - medical device

BIEFFE FIBER - medical device
Product Description

BIEFFE FIBER is a class IIa medical device with a laxative effect containing Fibersol®-2.
PRODUCT

The product is intended for the treatment of the symptoms and the prevention of constipation. BIEFFE FIBER improves symptoms ofconstipation by regularizing the stool frequency, facilitates the correct bowel function and prevents the recurrence of acute episodes of constipation.

INNOVATION FEATURES

BIEFFE FIBER is characterized by the presence of Fibersol®-2, a glucan with a branched structure, produced by the combination of heat and enzymatic treatment of cornstarch. The complex polymeric structure of this soluble fibre makes it mostly indigestible and non-absorbable from the gastrointestinal tract. Thanks to its intrinsic ability to retain a significant amount of water, Fibersol®-2 increases faecal bulkin the bowel, resulting in dilation of the intestine wall, and normalizes stool consistency. Through this physical mechanism, Fibersol®-2 improves intestinal transit both in terms of increased stool frequency and reduction in discomforts and annoyances related to defecation, thus by contributing to the maintenance of a good intestinal regularity and prevention ofthe recurrence of acute episodes of the disorder.

Biofarma S.p.A.

  • IT
  • 2015
    On CPhI since
  • 5
    Certificates
  • 500 - 999
    Employees
Specifications

Biofarma S.p.A.

  • IT
  • 2015
    On CPhI since
  • 5
    Certificates
  • 500 - 999
    Employees

More Products from Biofarma S.p.A.

  • EPATREX

    Product EPATREX

    FOOD SUPPLEMENT WITH CHROMIUM, MILK THISTLE AND LACTIC FERMENTS Supports the body's liver and digestive function, helping to maintain normal blood glucose levels

    PRODUCT

    Our innovation is represented both by the right choice of scientifically sound natural ingredients for the synergic mix in the NAFLD management and by the development of a trilayer tablet that allow a bioavailable and stable administration of actives.

    INNOVATIVE PRODUCTS

    Efficacy is due to the synergic effect of the different mechanisms of action of the active ingredients chosen.
    • Silybum marianum: a botanical ingredient with known ability to improve liver enzymatic activity and with antioxidant properties;
    • Probiotic: an innovative component capable of regulating metabolic parameters such as lipids and sugars and with anti-inflammatory effects on the intestinal microbiota;
    • Chromium: a mineral ingredient with clinically proven ability to maintain and regulate normal blood glucose and triglycerides levels.




  • SAME UP

    Product SAME UP

    FOOD SUPPLEMENT WITH S-ADENOSYLMETHIONINE (SAMe) AND LACTIC FERMENTS
    Helps to manage mood swings

    PRODUCT

    Our nutraceutical product helps border-line patients with predepression syndrome.
    The start of a depressive disorder is not the same as a passing blue mood. Without treatment, or with the wrong one, symptoms can last for weeks, months, or years.


    INNOVATIVE FEATURES

    Our innovation is represented both by the right choice of scientifically sound natural ingredients for the synergic mix and by the development of a bilayer tablet that allow a bioavailable and stable administration of actives. The efficacy of our unique product is due to the synergy of 2 different mechanisms of action:
    • SAM-e: regulates the hormones and neurotransmitters that influence mood.                           
    • Psychobiotic “Lactobacillus plantarum”:: a psicobiotic who treats dysbiosis by improving intestinal permeability that generates chronic inflammation and by controlling cortisol production.
  • GLICOSET

    Product GLICOSET

    FOOD SUPPLEMENT WITH CHROMIUM, MATE AND WHITE MULBERRYPromotes cholesterol and triglyceride control, helping to reduce cardiovascular desease risk


    PRODUCT

    Our product, at two concentrations, can help most people before developing diabetes and it is well accepted by patients without side effects.
    INNOVATIVE FEATURES 
    Innovation is represented by the right choice of natural ingredients that act as a synergic mix. 
    • Ilex paraguariensis (yerba mate): improves glycaemic and lipid profiles of type 2 diabetes and pre-diabetes individuals.
    • Morus alba (white mulberry): suppresses postprandial hyperglycemia and hyperinsulinemia.
    • Chromium: acts as an ‘insulin-sensitizing’ agent
    All three raw materials act on the reduction of cholesterol and triglyceride levels.

  • TENSRED PLUS

    Product TENSRED PLUS

    FOOD SUPPLEMENT WITH ARGININE, COENZYME Q10, LACTIC FERMENTS AND THIAMINESupports blood pressure levels and cholesterol control

    PRODUCT

    Our innovation is represented by the right choice of scientifically sound natural ingredients that act as a synergic mix and in the development of a threelayer tablet with differential release timing, which provide a natural management of Pre-Hypertension.

    INNOVATIVE FEATURES

    The efficacy of our unique product is due to the synergy of 4 different mechanisms of action:
    • L-Arginine: it is a semi essential amino acids, it is considered a vasodilator of vasal lumen and is the natural substrate for NO synthase, responsible for the production of the relaxation factor derived from endothelium.
    • Vitamin B1 (Thiamine): EFSA claim “contributes to the normal function of heart”.
    • L. plantarum LPLDL ®: it has been demonstrated that probiotics and their products can improve blood pressure (BP) through mechanisms including improving total cholesterol and low-density lipoprotein cholesterol levels, reducing blood glucose level and insulin resistance and regulating the renin–angiotensin system.
    • Coenzyme Q10: it is a micronutrient can act as an antioxidant. Studies have shown that ingredient deficiency is associated with cardiovascular disease
  • REGLICEM

    Product REGLICEM

    FOOD SUPPLEMENT WITH TURMERIC, BERBERINE, BANABA, INOSITOL, AND CHROMIUM

    Contributes to the maintenance of normal blood glucose levels

    PRODUCT


    Our product, can help most people before developing diabetes and it is well accepted by patients without side effects.

    INNOVATIVE FEATURES

    Innovation is represented by the right choice of scientifically natural ingredients that act as a synergic mix. The efficacy of our unique product is due to the synergy of 5 different mechanisms of action:
    • Curcuma longa (turmeric): is effective in reducing glycemia and hyperlipidemia and improves insulin sensitivity.
    • Berberis vulgaris (barberry): promotes glucose and HbA1c lowering in patients with diabetes type II.
    • Lagerstroemia speciosa (banaba): exhibits hypoglycemic, antihyperlipidemic and antioxidant activities.
    • Inositol: is effective in decreasing the level of insulin resistance.
    • Chromium: acts as an ‘insulin-sensitizing’ agent
  • SEOXIN

    Product SEOXIN

    FOOD SUPPLEMENT WITH MORINGA, GINSENG AND RUTIN
    Supports the treatment of erectile dysfunction

    PRODUCT

    The goal of our nutraceutical is to act as an endothelial protector to prevent damage that could result in erectile dysfunction, in patients with metabolic syndrome or in general with specific risk factors (smoking, alcohol, dyslipidaemia, obesity, poor physical activity, hypertension, diabetes).

    INNOVATIVE FEATURES

    Our innovation is represented by the right choice of scientifically sound natural ingredients that act as a synergic mix and in the development of a multilayer tablet that allows the association of different ingredients and provides different timing for the release of active ingredients, prolonging the overall effect.
    • Ginseng: rapid release to offer the antioxidant and organ protective actions, associated with enhanced NO synthesis in the endothelium of the lung, heart, kidney and corpus cavernosum.
    • Moringa oleifera: intermediate release to offer more substrate to the nitric oxide synthase by inhibiting the arginase and to exert its effect at metabolic level.
    • Rutin: delayed release to offer radical scavenging effect to provide protection to the endothelium and inhibition of PDE5 and to maintain high levels of Nitric Oxide.
  • SEREDREAM

    Product SEREDREAM

    FOOD SUPPLEMENT WITH MAGNESIUM AND PLANT EXTRACTS

    Promotes relaxation and restful sleep

    PRODUCT

    Our product is useful for safe and optimal sleep disorders management; 4 synergic natural ingredients in a 3 layer tablet to create a unique, natural, innovative and effective remedy for a night-long safe and effective management of a disease in rapid growth 

    INNOVATIVE FEATURES

    Our innovation is represented by the right choice of scientifically sound natural ingredients that act as a synergic mix and in the development of a threelayer tablet with differential release timing, that provide a natural management of sleep disorders.
    • Crocus sativus extract: it has a cardiac muscle relaxant action that favours a gradual falling asleep. Moreover exhibits antidepressant-like activity, inhibiting the re-uptake of dopamine and norepinephrine, and inhibiting the reuptake of serotonin.
    • Magnesium: EFSA claim “it contributes to the reduction of tiredness and fatigue”. A decline in its quantity is associated with various symptoms such as nausea, muscular weakness and fatigue.
    • Eucommia ulmoide: increases the sleep ratio, lengthens the sleep time and shortens sleep latency. 
    • Magnolia officinalis extract:  exhibits anxiolytics and antidepressant activities inducing the sleep, related to the activation of benzodiazepine receptors, which is similar to that of diazepam.
  • URICEMIN

    Product URICEMIN

    FOOD SUPPLEMENT WITH FLAVONOIDS, CARNOSINE AND BROMELINSupports the treatment of hyperuricemia-gout

    PRODUCT

    The goal of our nutraceutical is to facilitate the dissolution of urate crystals and prevent their formation in patients with borderline uric acid levels.

    INNOVATIVE FEATURES

    The efficacy of our unique product is due to the synergy of 4 different mechanisms of action: 
    • Quercetin: inhibits the activity of the enzyme xanthine oxide-reductase which catalyzes the final reaction of uric acid synthesis.
    • Rutin: is also able to enhance renal excretion of urate.
    • Bromelain: exerts analgesic and anti-inflammatory properties due to its ability to influence prostaglandin synthesis.
    • L-carnosine: modulates the reabsorption of uric acid in the glycolytic process, reducing uric acid levels
  • ACID STOP - medical device

    Product ACID STOP - medical device

    ACID STOP is a class IIa medical device, having an anti-acidaction and containing calcium carbonate, magnesium hydroxide, sodium citrateand simethicone.

    PRODUCT

    The product is indicated for the treatment of burning and stomach pain caused by excess acidity. The product is also useful in treating symptoms associated with gastroesophageal reflux and dyspepsia (such as digestive difficulties, burning, heaviness).

    INNOVATIVE FEATURES

    ACID STOP formula is characterized by calcium carbonate, magnesium hydroxide, sodium citrate and it is enriched with simethicone. Calcium carbonate, magnesium hydroxide and sodium citrate give the product a good ability to neutralize excess acidity in the gastroesophageal tract, responsible for the onset of heartburn. They are in fact basic salts, which by means of an acid-base reaction buffer the acidity of gastric juices and acid vapors produced at the gastroesophageal level, thus giving rapid relief from pain and heartburn due to hyperacidity and by exerting a protective and soothing action on the gastro-esophageal mucosa. The presence of simethicone, a substance that has the ability to decrease the surface tension of the gas bubbles present in the gastrointestinal tract facilitating its expulsion, reduces the sensation of bloating and abdominal distention. Clinical studies have demonstrated the safety and short-term efficacyof oral antacid combinations for the symptomatic treatment of burning and stomach pain associated with hyperacidity.

  • GASTRO STOP - medical device

    Product GASTRO STOP - medical device

    GASTRO STOP is a class IIa medical device, having an anti-reflux action and containing sodium alginate, sodium bicarbonate, sodium carbonateand calcium carbonate.

    PRODUCT

    The product is indicated to reduce gastro-oesophageal reflux diseasesymptoms, including heartburn, gastric pyrosis during pregnancy, reflux oesophagitis, acid regurgitation, maldigestion, reflux night-time symptoms, cough and laryngo pharyngeal inflammation. It acts quickly to stop acid reflux, reducing heart burn and protecting the oesophageal mucosa.

    INNOVATION FEATURES

    The product mechanically prevents the rise of gastric contents towards the esophagus (gastro-esophageal reflux). The alginate, in contact with the acidic pH of the stomach, reacts to form a low-density viscous gel. The carbonates, in the presence of acid, favor the development of carbon dioxide bubbles that remain trapped in the gel, allowing it to float on the surface of the gastric content, in correspondence with the esophageal sphincter. The resulting raft, whose strength is favoured by the presence of calcium ions, significantly reduces reflux episodes, helping to preserve the esophagus from further irritative attacks and giving rapid relief from reflux-related symptoms. Carbonates also help to buffer the excess acidity of gastric juice, reducing the burning feeling.
  • GAS & BLOATING REMEDY - medical device

    Product GAS & BLOATING REMEDY - medical device

    GAS & BLOATING REMEDY is a class IIa medical device having anti-meteoric action and containing simethicone.

    PRODUCT

    The product is indicated  in case of gastrointestinal disorders caused by an excessive production of gas, such as flatulence, meteorism, eructation, bloating and abdominal cramps. It is useful in case of irritable bowel syndrome (IBS) for the symptomatic treatment of abdominal bloating.

    INNOVATIVE FEATURES

    The beneficial effects of our product are due to the action of simethicone. The action of simethicone, a methyl siloxane polymer which, since inert, is not absorbed from the digestive tract and does not interfere with the digestive processes, is purely physical andtakes place at the gastro-intestinal level. It can reduce surface tension of gas bubbles present there, facilitating their dispersion and, therefore, their expulsion.
  • BIEFFE LAX - medical device

    Product BIEFFE LAX - medical device

    BIEFFE LAX is a class IIa medical device with a laxative effect containing macrogol.
    PRODUCT 

    The product is intended for the symptomatic treatment of constipation. BIEFFE LAX fights the annoying symptoms of constipation and helps prevent the formation of hard and dehydrated stools (faecal impaction).

    INNOVATION FEATURES

    BIEFFE LAX action is purely mechanical and takes place in the bowel. It is due to macrogol, a polymer of ethylene glycol, which is inert and therefore is not absorbed orfermented by the flora resident in the digestive tract. Macrogol can form hydrogen bonds with water molecules, thus maintainingthe water used for intake in the stoolsand opposing its resorption in the large intestine. It softens faecal bulk and facilitates evacuation. It speeds intestinal transit, by favouring peristalsis. Its mode of action is non-specific, independent from the pathogenesis of the disorder. Macrogol does not lead to electrolytic imbalances when taken with the required amount of liquid.

Biofarma S.p.A. resources

  • Brochure Biofarma Group Presentation

    The CDMO that grows by innovatingBiofarma Group is the new Italian and European market leader in the development, manufacture and packaging of supplements, medical devices, probiotic-based drugs and cosmetics, exclusively for third parties.

  • Video Biofarma Group - Multilayer Technology

    Technology for the oral administration – in a single product – of formulations with active substances or mixtures of active ingredients for diversified sustained and controlled release, for a more efficacious action in the body.
  • Video Biofarma Group - BOV Technology

    BOV technology has revolutionised the production of aerosols pressurised with liquid or compressed gases. The product is contained inside a bag connected to the valve, that is immersed in a non-chemical, non-flammable compressed air-based propellant that guarantees absolute safety and does away with emissions that are harmful for the environment.
  • Video Biofarma Group - Dry-Cap/M-Cap Technology

    Dry-Cap and M-Cap are based on a special two-phase packaging technology making it possible to enclose and at the same time separate in the same main pack, the solid component (powder) and liquid component of the product. This type of packaging is particularly well-suited to probiotic-based drugs, but it can also be used for vitamins, minerals and other micronutrients.
  • Video Biofarma Group - T-Win Technology

    T-Win is a powder packaging system that has been patented in Italy and is pending international patent. A sachet with two separate chambers makes it possible to package different but mixable powders that need to be kept separate until use. The two chambers can be opened at the same time with a single gesture.
  • Video Biofarma Group - company overview

    Biofarma Group is the new Italian and European market leader in the development, manufacture and packaging of supplements, medical devices, probiotic-based drugs and cosmetics, exclusively for third parties.

Recommended products